RXLENS · MARKET INTELLIGENCE · PLATFORM SHOWCASE

London Weight-Management GLP-1 Market — Interactive Dashboard

Wegovy (Novo Nordisk) vs Mounjaro (Eli Lilly)  |  NHS secondary care, Greater London · Apr 2025–Mar 2026 · Source: NHS England SCMD

NHS Trust
Month
Measure
Weekly maintenance dose (mg/week) — edit to test the assumption; patient-weeks recalculate
Note: NHS acute Trusts in Greater London only; patient figures are modelled estimates. Mounjaro is licensed for diabetes and weight management — not separable here.

Monthly trend

Market share

Top NHS Trusts (largest first)

NHS Trust league table

NHS TrustWegovyMounjaroTotal